- Home
- AMIX vs FOXO Comparison
AMIX vs FOXO Comparison
Compare AMIX & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMIX
- FOXO
- Stock Information
- Founded
- AMIX 2014
- FOXO 2019
- Country
- AMIX United States
- FOXO United States
- Employees
- AMIX N/A
- FOXO N/A
- Industry
- AMIX
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- AMIX
- FOXO Technology
- Exchange
- AMIX NYSE
- FOXO Nasdaq
- Market Cap
- AMIX 5.5M
- FOXO 4.9M
- IPO Year
- AMIX N/A
- FOXO N/A
- Fundamental
- Price
- AMIX $2.97
- FOXO $0.21
- Analyst Decision
- AMIX
- FOXO
- Analyst Count
- AMIX 0
- FOXO 0
- Target Price
- AMIX N/A
- FOXO N/A
- AVG Volume (30 Days)
- AMIX 58.5K
- FOXO 2.3M
- Earning Date
- AMIX 02-13-2025
- FOXO 11-19-2024
- Dividend Yield
- AMIX N/A
- FOXO N/A
- EPS Growth
- AMIX N/A
- FOXO N/A
- EPS
- AMIX N/A
- FOXO N/A
- Revenue
- AMIX N/A
- FOXO $1,341,000.00
- Revenue This Year
- AMIX N/A
- FOXO N/A
- Revenue Next Year
- AMIX N/A
- FOXO N/A
- P/E Ratio
- AMIX N/A
- FOXO N/A
- Revenue Growth
- AMIX N/A
- FOXO 196.03
- 52 Week Low
- AMIX $2.55
- FOXO $0.13
- 52 Week High
- AMIX $93.80
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- AMIX 47.86
- FOXO 40.68
- Support Level
- AMIX $2.76
- FOXO $0.20
- Resistance Level
- AMIX $2.95
- FOXO $0.25
- Average True Range (ATR)
- AMIX 0.16
- FOXO 0.02
- MACD
- AMIX 0.08
- FOXO 0.00
- Stochastic Oscillator
- AMIX 72.83
- FOXO 16.67
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.